Literature DB >> 22281102

Prevalence of item level negative symptoms in first episode psychosis diagnoses.

John Lyne1, Brian O'Donoghue, Elizabeth Owens, Laoise Renwick, Kevin Madigan, Anthony Kinsella, Mary Clarke, Niall Turner, Eadbhard O'Callaghan.   

Abstract

UNLABELLED: The relevance of negative symptoms across the diagnostic spectrum of the psychoses remains uncertain. The purpose of this study was to report on prevalence of item and subscale level negative symptoms across the first episode psychosis (FEP) diagnostic spectrum in an epidemiological sample, and to ascertain whether items and subscales were more prevalent in a schizophrenia spectrum diagnoses group compared to an 'all other psychotic diagnoses' group. We measured negative symptoms in 330 patients presenting with FEP using the Scale for Assessment of Negative Symptoms (SANS), and ascertained diagnosis using the Structured Clinical Interview for DSM IV. Prevalence of SANS items and subscales were tabulated across all psychotic diagnoses, and logistic regression analysis determined which items and subscales were predictive of schizophrenia spectrum diagnoses. SANS items were most prevalent in schizophrenia spectrum conditions but frequently presented in other FEP diagnoses, particularly substance induced psychotic disorder and Major Depressive Disorder. Brief psychotic disorder and bipolar disorders had low levels of negative symptoms. SANS items and subscales which significantly predicted schizophrenia spectrum diagnoses, were also frequently present in some of the other psychotic diagnoses.
CONCLUSIONS: SANS items have high prevalence in FEP, and while commonest in schizophrenia spectrum conditions are not restricted to this diagnostic subgroup.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22281102     DOI: 10.1016/j.schres.2012.01.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains.

Authors:  Wing Chung Chang; Gregory P Strauss; Anthony O Ahmed; Sandra C Y Wong; Joe K N Chan; Edwin H M Lee; Sherry K W Chan; Christy L M Hui; Sydney H James; Hannah C Chapman; Eric Y H Chen
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

2.  Early-Stage Negative Symptom Trajectories and Relationships With 13-Year Outcomes in First-Episode Nonaffective Psychosis.

Authors:  Wing Chung Chang; Ryan Wui Hang Ho; Jennifer Yee Man Tang; Corine Sau Man Wong; Christy Lai Ming Hui; Sherry K W Chan; Edwin M H Lee; Yi Nam Suen; Eric Y H Chen
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

3.  Epidemiological and clinical characterization following a first psychotic episode in major depressive disorder: comparisons with schizophrenia and bipolar I disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).

Authors:  Olabisi Owoeye; Tara Kingston; Paul J Scully; Patrizia Baldwin; David Browne; Anthony Kinsella; Vincent Russell; Eadbhard O'Callaghan; John L Waddington
Journal:  Schizophr Bull       Date:  2013-05-28       Impact factor: 9.306

4.  Reduced safety processing during aversive social conditioning in psychosis and clinical risk.

Authors:  Megan Quarmley; Ruben C Gur; Bruce I Turetsky; Anna J Watters; Warren B Bilker; Mark A Elliott; Monica E Calkins; Christian G Kohler; Kosha Ruparel; Petra Rupert; Raquel E Gur; Daniel H Wolf
Journal:  Neuropsychopharmacology       Date:  2019-05-21       Impact factor: 7.853

Review 5.  Negative symptoms in schizophrenia.

Authors:  Sayantanava Mitra; Tathagata Mahintamani; Anjana Rao Kavoor; S Haque Nizamie
Journal:  Ind Psychiatry J       Date:  2016 Jul-Dec

6.  Similarities and differences of functional connectivity in drug-naïve, first-episode adolescent and young adult with major depressive disorder and schizophrenia.

Authors:  Shengnan Wei; Fay Womer; Haiyang Geng; Xiaowei Jiang; Qian Zhou; Miao Chang; Yifang Zhou; Yanqing Tang; Fei Wang
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

7.  Clinical characterization of brief psychotic disorders triggered by the COVID-19 pandemic: a multicenter observational study.

Authors:  María José Valdés-Florido; Álvaro López-Díaz; Fernanda Jazmín Palermo-Zeballos; Nathalia Garrido-Torres; Paula Álvarez-Gil; Iván Martínez-Molina; Victoria Eugenia Martín-Gil; Elena Ruiz-Ruiz; Macarena Mota-Molina; María Paz Algarín-Moriana; Antonio Hipólito Guzmán-Del Castillo; Ángela Ruiz-Arcos; Rafael Gómez-Coronado; Sara Galiano-Rus; Alfonso Rosa-Ruiz; Juan Luis Prados-Ojeda; Luis Gutierrez-Rojas; Benedicto Crespo-Facorro; Miguel Ruiz-Veguilla
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-04-03       Impact factor: 5.270

8.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

9.  Impaired Effort Allocation in Patients with Recent-Onset Schizophrenia and Its Relevance to Negative Symptoms Assessments and Persistent Negative Symptoms.

Authors:  Ezgi Ince Guliyev; Sinan Guloksuz; Alp Ucok
Journal:  J Clin Med       Date:  2022-08-28       Impact factor: 4.964

10.  The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial.

Authors:  Lei Chen; Joseph A Johnston; Bruce J Kinon; Virginia Stauffer; Paul Succop; Tiago R Marques; Haya Ascher-Svanum
Journal:  BMC Psychiatry       Date:  2013-11-28       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.